News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
578,010 Results
Type
Article (39332)
Company Profile (314)
Press Release (538364)
Section
Business (164322)
Career Advice (2391)
Deals (29622)
Drug Delivery (102)
Drug Development (77520)
Employer Resources (142)
FDA (14013)
Job Trends (12596)
News (289796)
Policy (27650)
Tag
Academia (2575)
Alliances (41791)
Alzheimer's disease (1370)
Approvals (13990)
Artificial intelligence (209)
Bankruptcy (316)
Best Places to Work (10406)
Biotechnology (255)
Breast cancer (232)
Cancer (1750)
Cardiovascular disease (144)
Career advice (2007)
CAR-T (130)
Cell therapy (376)
Clinical research (62345)
Collaboration (677)
Compensation (269)
COVID-19 (2497)
C-suite (182)
Data (1666)
Diabetes (214)
Diagnostics (5602)
Earnings (60073)
Employer resources (130)
Events (86901)
Executive appointments (596)
FDA (14908)
Funding (608)
Gene therapy (276)
GLP-1 (676)
Government (4123)
Healthcare (16821)
Infectious disease (2612)
Inflammatory bowel disease (132)
Interviews (517)
IPO (13932)
Job creations (2636)
Job search strategy (1647)
Layoffs (426)
Legal (5747)
Lung cancer (267)
Manufacturing (226)
Medical device (10729)
Medtech (10733)
Mergers & acquisitions (16042)
Metabolic disorders (573)
Neuroscience (1820)
NextGen: Class of 2025 (5722)
Non-profit (3961)
Northern California (1968)
Obesity (309)
Opinion (224)
Patents (170)
People (52886)
Phase I (19636)
Phase II (27626)
Phase III (20453)
Pipeline (771)
Postmarket research (2288)
Preclinical (8179)
Radiopharmaceuticals (250)
Rare diseases (345)
Real estate (4296)
Regulatory (19525)
Research institute (2188)
Resumes & cover letters (346)
Southern California (1757)
Startups (3073)
United States (17343)
Vaccines (576)
Weight loss (221)
Date
Last 7 days (760)
Last 30 days (2407)
Last 365 days (32243)
2025 (4910)
2024 (33066)
2023 (36979)
2022 (47771)
2021 (51255)
2020 (49043)
2019 (41378)
2018 (31213)
2017 (28932)
2016 (27373)
2015 (32041)
2014 (24526)
2013 (19718)
2012 (20882)
2011 (21843)
2010 (19719)
Location
Africa (712)
Arizona (151)
Asia (35193)
Australia (7048)
California (4557)
Canada (1659)
China (387)
Colorado (207)
Connecticut (203)
Europe (78697)
Florida (661)
Georgia (148)
Illinois (408)
Indiana (222)
Maryland (715)
Massachusetts (3434)
Michigan (185)
Minnesota (296)
New Jersey (1305)
New York (1289)
North Carolina (806)
Northern California (1968)
Ohio (149)
Pennsylvania (979)
South America (971)
Southern California (1757)
Texas (630)
Utah (145)
Washington State (438)
578,010 Results for "apim therapeutics as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA desires to share more information with the Company’s shareholders about the proposed merger between the Company and APIM Therapeutics.
November 21, 2022
·
6 min read
Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) today announces an update following the Extraordinary General Meeting held on 1 December at which the proposed merger transaction with APIM Therapeutics AS (“APIM”) did not obtain a sufficient majority of votes and was therefore voted down.
December 9, 2022
·
2 min read
Deals
Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA has today launched a new dedicated area on its website ( www.nordicnanovector.com ) with information in Norwegian for shareholders relating to its proposed merger with APIM Therapeutics (“APIM”).
November 25, 2022
·
6 min read
Deals
Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
Nordic Nanovector ASA will host a webcast, including a question and answers session on Thursday, November 24 at 4.30 P.M. CET.
November 23, 2022
·
3 min read
Press Releases
Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference
February 25, 2025
·
1 min read
Press Releases
Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
February 27, 2025
·
8 min read
Press Releases
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology
February 19, 2025
·
4 min read
Press Releases
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
February 20, 2025
·
2 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 57,801
Next
